Select from the search options to widen or narrow the search results.
Kidney Cancer (ECOG E2805)
The purpose of this study is to determine if either Sunitinib or Sorafenib can prevent recurrence of kidney cancer and to compare the effects of the Sunitinib and the Sorafenib with Placebo on kidney cancer to see which is better.
To Participate in the Study You Must:
Must be 18 years old
Must have renal cell carcinoma
Must not have any other cancer
For more information in Slinger /Elkorn Please Contact: Carol Thomas 414-649-5605 or carol.thomas@aurora.org
Principal Investigator, Rossana Madama, MD
For more information in Milwaukee please contact Pamela Rynes 414-649-6067 pam.rynes@auroa.org
Principle Investgator Sailaja Kumaraju, MD,
For information at Aurora BayCare Medical Center contact Lori McElrone, 920-288-4174 lori.mcelrone@aurora.org
Principal Investigator Dhiman Patel,M.D.
For more information in Oshkosh please Contact Barb Esselman, RN 920-456-7880 or barbara.esselman@aurora.org
Principal Investigator, Zahid Dar, MD
For more information in Sheboygan Please Contact Deb Gray, RN 920-457-6800 or deborah.gray@aurora.org
Principal Investigator,Santhosh Kumar, MD
Clinical trial location(s)
AMG - ABMC (incl. VLCC) 2845 Greenbrier Road Green Bay, WI 54308-8900
Aurora Lakeland Medical Center W3985 County Road NN Elkhorn, WI 53121
Aurora St. Luke's Medical Center 2900 West Oklahoma Avenue Milwaukee, WI 53215
VLCC Sheboygan (AMG) 1222 N 23rd Street Sheboygan, WI 53081-3171
VLCC - Elkhorn W3985 County Road NN Elkhorn, WI 53121
VLCC - Slinger 1061 East Commerce (Hwy. 60) Slinger, WI 53086
VLCC- Oshkosh 855 N Westhaven Dr Oshkosh, WI 54904
